Werner Verbiest
Impact in
- Virology top 2%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 11
- HIV/AIDS Research and Interventions 4
- Virology 6
- HIV Research and Treatment 6
- Co-authors
- Brendan Larder (7 shared papers)Kurt Hertogs (7 shared papers)Veronica Miller (2 shared papers)P. Richard Harrigan (1 shared paper)Robin Wood (1 shared paper)Joan Montaner (1 shared paper)Scott A. Wegner (1 shared paper)Marcus A. Conant (2 shared papers)
- Journals
- AIDS (6 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (2 papers)Antiviral Therapy (1 paper)PubMed (2 papers)UCL Discovery (University College London) (1 paper)
- Partner nations
- United StatesCanadaBelgium
In The Last Decade
Werner Verbiest
12 papers receiving 573 citations
Peers
Comparison fields: 5 of 38
- Virology 364
- Infectious Diseases 516
- Hepatology 23
- Microbiology 17
- Emergency Medicine 15
Countries citing papers authored by Werner Verbiest
This map shows the geographic impact of Werner Verbiest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Werner Verbiest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Werner Verbiest more than expected).
Fields of papers citing papers by Werner Verbiest
This network shows the impact of papers produced by Werner Verbiest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Werner Verbiest. The network helps show where Werner Verbiest may publish in the future.
Co-authors
The 25 scholars most cited alongside Werner Verbiest, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 138 | |
| 2 | 1999 | 104 | |
| 3 | 2001 | 99 | |
| 4 | 2001 | 84 | |
| 5 | 1996 | 76 | |
| 6 | 2002 | 37 | |
| 7 | 2001 | 33 | |
| 8 | 2001 | 16 | |
| 9 | 2003 | 6 | |
| 10 | Modest decreases in NNRTI susceptibility do not influence virological outcome in patients receiving initial NNRTI-containing triple therapy. | 2003 | 6 |
| 11 | A randomized controlled trial of the value of phenotypic testing in addition to genotypic testing for HIV drug resistance | 2005 | 2 |
| 12 | A simple and rapid flow cytometric method to measure lymphocyte activation in HIV+ subjects. Diminished response to pokeweed mitogen in early disease. | 1995 | 2 |
About Werner Verbiest
Werner Verbiest is a scholar working on Infectious Diseases, Virology, Emergency Medicine, Epidemiology and Organic Chemistry, having authored 12 papers that have together received 603 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (6 papers), HIV/AIDS Research and Interventions (4 papers), HIV-related health complications and treatments (2 papers) and Fungal Infections and Studies (1 paper). The work is most often cited by research in Virology (364 citations), Infectious Diseases (516 citations), Hepatology (23 citations), Microbiology (17 citations) and Emergency Medicine (15 citations). Werner Verbiest has collaborated with scholars based in United States, Canada and Belgium. Frequent co-authors include Brendan Larder, Kurt Hertogs, Veronica Miller, P. Richard Harrigan, Robin Wood, Joan Montaner, Scott A. Wegner, Marcus A. Conant, Neil M.H. Graham and Jeffrey P. Nadler. Their work appears in journals such as AIDS, JAIDS Journal of Acquired Immune Deficiency Syndromes, Antiviral Therapy, PubMed and UCL Discovery (University College London).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.